[613] | 1 | DVBCWRM1 ;ALB/CMM RESPIRATORY, MISC. DISEASES WKS TEXT - 1 ; 6 MARCH 1997
|
---|
| 2 | ;;2.7;AMIE;**12**;Apr 10, 1995
|
---|
| 3 | ;
|
---|
| 4 | ;
|
---|
| 5 | TXT ;
|
---|
| 6 | ;;A. Review of Medical Records:
|
---|
| 7 | ;;
|
---|
| 8 | ;;
|
---|
| 9 | ;;
|
---|
| 10 | ;;B. Medical History (Subjective Complaints):
|
---|
| 11 | ;;
|
---|
| 12 | ;; Comment on:
|
---|
| 13 | ;; 1. Fever and/or night sweats.
|
---|
| 14 | ;;
|
---|
| 15 | ;;
|
---|
| 16 | ;; 2. Weight loss or gain.
|
---|
| 17 | ;;
|
---|
| 18 | ;;
|
---|
| 19 | ;; 3. Daytime hypersomnolence.
|
---|
| 20 | ;;
|
---|
| 21 | ;;
|
---|
| 22 | ;; 4. Hemoptysis.
|
---|
| 23 | ;;
|
---|
| 24 | ;;
|
---|
| 25 | ;; 5. Describe current treatment such as anticoagulant, tracheostomy,
|
---|
| 26 | ;; CPAP, oxygen, or antimicrobial therapy.
|
---|
| 27 | ;;
|
---|
| 28 | ;;
|
---|
| 29 | ;; 6. If malignant disease, state initial treatment date, site of
|
---|
| 30 | ;; original tumor, type of tumor, types of treatment used, and
|
---|
| 31 | ;; date treatment is expected to end. If treatment has been
|
---|
| 32 | ;; completed, state date treatment was completed.
|
---|
| 33 | ;;
|
---|
| 34 | ;;
|
---|
| 35 | ;;C. Physical Examination (Objective Findings):
|
---|
| 36 | ;;
|
---|
| 37 | ;; Address each of the following as appropriate to the condition
|
---|
| 38 | ;; being examined and fully describe current findings:
|
---|
| 39 | ;; 1. Pulmonary Hypertension, RVH, cor pulmonale, or congestive
|
---|
| 40 | ;; heart failure.
|
---|
| 41 | ;;
|
---|
| 42 | ;;
|
---|
| 43 | ;; 2. Residuals of pulmonary embolism.
|
---|
| 44 | ;;
|
---|
| 45 | ;;
|
---|
| 46 | ;; 3. Respiratory Failure.
|
---|
| 47 | ;;
|
---|
| 48 | ;;
|
---|
| 49 | ;; 4. Evidence of chronic pulmonary thromboembolism.
|
---|
| 50 | ;;
|
---|
| 51 | ;;
|
---|
| 52 | ;; 5. If ankylosing spondylitis, is there restriction of the chest
|
---|
| 53 | ;; excursion and dyspnea on minimal exertion?
|
---|
| 54 | ;;
|
---|
| 55 | ;;
|
---|
| 56 | ;; 6. Describe all residuals of malignancy including those due to
|
---|
| 57 | ;; treatment.
|
---|
| 58 | ;;
|
---|
| 59 | ;;
|
---|
| 60 | ;;D. Diagnostic and Clinical Tests:
|
---|
| 61 | ;;
|
---|
| 62 | ;; 1. Pulmonary Function Tests, if indicated. When the results of
|
---|
| 63 | ;; pre-bronchodilator pulmonary function tests are NORMAL, post-
|
---|
| 64 | ;; bronchodilator studies are not required for VA evaluation
|
---|
| 65 | ;; purposes. IN ALL OTHER CASES, post-bronchodilator studies
|
---|
| 66 | ;; should be conducted unless contraindicated (because of allergy
|
---|
| 67 | ;; to medication, etc.) or if the veteran was on bronchodilators
|
---|
| 68 | ;; before the test and had taken his or her medication within a
|
---|
| 69 | ;; few hours of the study. An examiner who determines that a
|
---|
| 70 | ;; post-bronchodilator study should not be performed should
|
---|
| 71 | ;; provide an explanation of why not. If there is a disparity
|
---|
| 72 | ;; between the results of different pulmonary function tests
|
---|
| 73 | ;; (FEV-1, FVC, etc.), the examiner should indicate which test
|
---|
| 74 | ;; result is the best indicator of the veteran's level of
|
---|
| 75 | ;; pulmonary functioning.
|
---|
| 76 | ;; 2. If sleep apnea is suspected, order SLEEP STUDIES.
|
---|
| 77 | ;; 3. Chest X-ray if necessary to document sarcoidosis or other
|
---|
| 78 | ;; parenchymal disease.
|
---|
| 79 | ;; 4. Include results of all diagnostic and clinical tests conducted
|
---|
| 80 | ;; in the examination report
|
---|
| 81 | ;;
|
---|
| 82 | ;;
|
---|
| 83 | ;;E. Diagnosis:
|
---|
| 84 | ;;
|
---|
| 85 | ;;
|
---|
| 86 | ;;Signature: Date:
|
---|
| 87 | ;;END
|
---|